James Geller on Muck Rack

James Geller

Cincinnati
As seen in: Color Research & Application, Nature, Wiley, Wiley Online Library, MDPI, EClinicalMedicine, Texas Medical Center, OncLive, Archives of Pathology, The Jewish Link of New Jersey and
I'm a 43 y/o, father of 3, living in Cincinnati Ohio, working as a Pediatric Oncologist.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with James

Contact James, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321

|
By James Geller
| Texas Medical Center
Pediatric Blood & Cancer Author MSS Humans, Rhabdoid Tumor, Kidney Neoplasms, Female, Male, Child, Preschool, Antineoplastic Combined Chemotherapy Protocols, Infant, Child, Etoposide, Survival Rate, Soft Tissue Neoplasms, Cyclophosphamide, Vincristine, Prospective Studies, Carboplatin, Doxorubicin, Follow-Up Studies, Adolescent, Prognosis, Wilms Tumor, chemotherapy, pediatric oncology, renal, rhabdoid tumor, tumors yes Geller, James I; Renfro, Lindsay A; Grundy, Paul E; et al., "Rhabdoid...
Open in Who Shared Issue with article?

Paediatric Therapeutic Development Workshop on rhabdoid tumours - British Journal of Cancer

|
By Jan J. Molenaar, Jaclyn A. Biegel, Patricia Blanc, Susan N. Chi, Sam Daems, Laura Danielson, Jarno Drost, Michael C. Frühwald, Amar Gajjar, James Geller, annie huang, Pascal D. Johann, Pamela R Kearns, Karsten Nysom, Suzanne O’Connor, Michael Ortiz, Jenny Parker, Seema Patel, Sheena M Patel, Charles Roberts, Daniel Williamson, Joanna S. Yi, Andrew Pearson, David Jenkinson , Marcel Kool, Franck Bourdeaut, Innovative Therapies, Claudia Montiel Equihua, Itziar Areso, Niels E. Franke
| Nature
Abstract Rhabdoid tumours (RT) are malignancies of the central nervous system, kidneys, liver and soft tissues that most commonly affect very young children with survival rates below 30% in high-risk cohorts. Treatment entails surgery, intensive chemotherapy and radiotherapy, associated with substantial short- and long-term toxicities. There is an unmet need to develop targeted therapies for RT to improve patient outcomes and mitigate the toxicities of current therapy.
Open in Who Shared Issue with article?

Anti‐Tumor Activity of Paclitaxel‐Containing Regimens in Recurrent/Refractory Wilms Tumor

|
By Alissa R. Groisser, Blood Disorders, Amy K. Frantz, James Geller
| Wiley Online Library
Background The Pediatric Oncology Group P9262 Phase 2 study of single-agent paclitaxel demonstrated one complete response (CR), one partial response (PR), and four with stable disease (SD) among 15 patients with recurrent Wilms tumor (WT). Based on this activity, paclitaxel-containing regimens have been used as salvage therapy for treatment-refractory WT.
Open in Who Shared Issue with article?
See all 21 licensed articles (22 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with James

Contact James, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified